Literature DB >> 16840789

Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells.

Qiang Wu1, Xi Chen, Jinqiu Zhang, Yuin-Han Loh, Teck-Yew Low, Weiwei Zhang, Wensheng Zhang, Siu-Kwan Sze, Bing Lim, Huck-Hui Ng.   

Abstract

Embryonic stem (ES) cells are pluripotent cells with self-renewing property. Nanog is a homeobox transcription factor required to maintain ES cells in a non-differentiated state. Using affinity purification coupled to liquid chromatography-tandem mass spectrometry analysis, we identified Sall4 as a Nanog co-purified protein. Co-immunoprecipitation and glutathione S-transferase pulldown experiments confirmed the interaction between Nanog and Sall4. We showed that Nanog and Sall4 co-occupied Nanog and Sall4 enhancer regions in living ES cells. Knockdown of Nanog or Sall4 by RNA interference led to a reduction in Nanog and Sall4 enhancer activities, providing evidence that these factors are positively regulating these enhancers. Importantly, co-transfection of Sall4 with these ES cell-specific enhancers led to transactivation in heterologous somatic cells. Chromatin immunoprecipitation experiments also showed that Sall4 co-occupied many Nanog binding sites in ES cells. Our data implicate Sall4 as an important component of the transcription regulatory networks in ES cells by cooperating with Nanog. We suggest that Sall4 and Nanog form a regulatory circuit similar to that of Oct4 and Sox2. This study highlights the extensive regulatory loops connecting genes, which encode for key transcription factors in ES cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840789     DOI: 10.1074/jbc.C600122200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  116 in total

1.  Phosphatase and tensin homolog regulates the pluripotent state and lineage fate choice in human embryonic stem cells.

Authors:  Jackelyn A Alva; Grace E Lee; Erika E Escobar; April D Pyle
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

2.  Differential roles of Sall4 isoforms in embryonic stem cell pluripotency.

Authors:  Sridhar Rao; Shao Zhen; Sergei Roumiantsev; Lindsay T McDonald; Guo-Cheng Yuan; Stuart H Orkin
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

Review 3.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

4.  NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.

Authors:  Chia-Lin Chen; Dinesh Babu Uthaya Kumar; Vasu Punj; Jun Xu; Linda Sher; Stanley M Tahara; Sonja Hess; Keigo Machida
Journal:  Cell Metab       Date:  2015-12-24       Impact factor: 27.287

5.  A gene regulatory network in mouse embryonic stem cells.

Authors:  Qing Zhou; Hiram Chipperfield; Douglas A Melton; Wing Hung Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-10       Impact factor: 11.205

6.  Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells.

Authors:  Yuin-Han Loh; Weiwei Zhang; Xi Chen; Joshy George; Huck-Hui Ng
Journal:  Genes Dev       Date:  2007-10-15       Impact factor: 11.361

Review 7.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

8.  SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases.

Authors:  Markku Miettinen; Zengfeng Wang; Peter A McCue; Maarit Sarlomo-Rikala; Janusz Rys; Wojciech Biernat; Jerzy Lasota; Yi-Shan Lee
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

9.  Defined factors induce reprogramming of gastrointestinal cancer cells.

Authors:  Norikatsu Miyoshi; Hideshi Ishii; Ken-ichi Nagai; Hiromitsu Hoshino; Koshi Mimori; Fumiaki Tanaka; Hiroaki Nagano; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

10.  Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target.

Authors:  Shikiko Ueno; Jiayun Lu; Jie He; Ailing Li; Xiaoxian Zhang; Jerome Ritz; Leslie E Silberstein; Li Chai
Journal:  Exp Hematol       Date:  2014-01-23       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.